Newborn Blood Spot Screening Card Market Size by Applications, by Type, by End-User, by Deployment & by Technology 2032
Global Newborn Blood Spot Screening Card Market was valued at USD 0.15 Billion in 2022 and is projected to reach USD 0.25 Billion by 2030, growing at a CAGR of 7.8% from 2024 to 2030.
The Newborn Blood Spot Screening Card Market is experiencing significant growth, driven by the increasing awareness of the importance of early disease detection in infants. Newborn screening cards are critical for diagnosing various genetic, metabolic, and endocrine disorders shortly after birth. These cards, typically containing dried blood spots collected from a heel prick, provide an invaluable tool for identifying conditions that, if untreated, can lead to severe health complications or even death.
The rise in global healthcare awareness has led to higher adoption rates of newborn blood spot screening programs, particularly in developed countries where the healthcare infrastructure supports comprehensive newborn care. The market's growth is also attributed to the advancements in screening technologies, allowing for the detection of more disorders with higher accuracy and efficiency. As a result, healthcare providers are increasingly relying on these screening cards to identify conditions such as cystic fibrosis, phenylketonuria, and hypothyroidism at an early stage.
Governments and health organizations across the world are strengthening their efforts to include newborn screening as part of national health programs. This has created a surge in demand for high-quality blood spot screening cards. Moreover, the cards are cost-effective, making them accessible for widespread use even in resource-limited settings. Their ability to facilitate the early intervention of life-threatening conditions has contributed to the broader acceptance and implementation of newborn blood screening programs.
The ongoing innovations in biotechnology and the growing availability of advanced diagnostic tools are expected to further enhance the capabilities of newborn blood spot screenings. As a result, the market is poised for continued expansion, offering promising opportunities for stakeholders in the healthcare and medical diagnostics sectors.
Get an In-Depth Research Analysis of the Global Newborn Blood Spot Screening Card Market Size And Forecast [2025-2032]
Who are the largest Global manufacturers in the Newborn Blood Spot Screening Card industry?
- NHS
- Perinatal Services BC
- VCGS
- Eastern Business Forms
- Inc
- RDA Spot
- Emergen Research
- QIAGEN
- PerkinElmer
- Roche Holding AG
- SHIMADZU CORPORATION
- Danaher
- Gentueri
- Neoteryx
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Newborn Blood Spot Screening Card Market Size And Forecast [2025-2032]
What are the factors driving the growth of the Global Newborn Blood Spot Screening Card Market?
Growing demand for below applications around the world has had a direct impact on the growth of the Global Newborn Blood Spot Screening Card Market
- Hospital
- Maternal and Child Health Hospital
- Blood Collection Agency
- Other
What are the types of Newborn Blood Spot Screening Card available in the Market?
Based on Types the Market is categorized into Below types that held the largest Newborn Blood Spot Screening Card market share In 2023.
- Whatman 903
- Ahlstrom 226
- Others
Which regions are leading the Global Newborn Blood Spot Screening Card Market?
- Global (United States, Global and Mexico)
- Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
- Asia-Pacific (China, Global, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
- South America (Brazil, Argentina, Columbia, etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Newborn Blood Spot Screening Card Market Research Analysis
Detailed TOC of Global Newborn Blood Spot Screening Card Market Research Report, 2024-2032
1. Introduction of the Global Newborn Blood Spot Screening Card Market
- Overview of the Market
- Scope of Report
- Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
- Data Mining
- Validation
- Primary Interviews
- List of Data Sources
4. Global Newborn Blood Spot Screening Card Market Outlook
- Overview
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Porters Five Force Model
- Value Chain Analysis
5. Global Newborn Blood Spot Screening Card Market, By Type
6. Global Newborn Blood Spot Screening Card Market, By Application
7. Global Newborn Blood Spot Screening Card Market, By Geography
- Global
- Europe
- Asia Pacific
- Rest of the World
8. Global Newborn Blood Spot Screening Card Market Competitive Landscape
- Overview
- Company Market Ranking
- Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768